Posts Tagged ‘IBISWorld’
Donations, Grants & Endowment in the US Industry Market Research Report Now Available from IBISWorld
Los Angeles, CA (PRWEB) September 04, 2012
In the past five years, the Donations, Grants and Endowment industry has endured adverse conditions due to the economic downturn and volatility in the financial markets. In this report, revenue consists of contributions, grants, investment income and realized gains. Prior to 2008, contributions helped drive double-digit revenue growth as wealthy individuals looked into philanthropy, making significant donations to foundations and driving industry revenue. However, according to IBISWorld industry analyst Anna Son, Industry revenue was crippled as businesses and individuals curbed their giving as a result of the recession and credit crisis. Consequently, IBISWorld estimates that industry revenue will decline at an average annual rate of 4.7% to $ 80.9 billion over the five years to 2012. However, as the economy continues to recover, industry revenue is expected to rebound 3.7% in 2012.
Due to the poor financial market performance, foundations struggled to generate investment income, further hurting revenue during the recession. Additionally, grantmaking foundations’ ability to reinvest profit into their company, as profit margins plunged from about 8.2% in 2007 to 5.1% in 2012. However, after the two consecutive years of a double-digit decline, revenue for the Donations, Grants and Endowment industry surged by 18.7% in 2010. This recovery was a result of large companies beefing up their charitable giving, including Walmart, Goldman Sachs, Citigroup and others. Moreover, the commitment of many foundations to maintain their grant budgets or reducing the extent of reductions relative to their assets helped offset what would have been even great declines in foundation giving since 2009. Foundations also benefited from the relatively low level of competition that they face from other organizations. While the majority of industry operators are smaller organizations, even the largest foundations focus on giving to local causes, meaning that there is space in the market for most industry operators to coexist, says Son. For example, the Bill and Melinda Gates Foundation gives to charities in the Northwest region, while the Lilly Endowment is a major contributor to charities and causes in Indiana; however, neither entity competes with the other. Furthermore, the myriad of charitable causes, both domestically and internationally, ensures that market participants usually find their niche.
Industry revenue is forecast to increase steadily over the next five years. During this period, demand for industry services is expected to remain stable due to charities’ and individuals’ continued reliance on foundation giving; healthcare and education will continue to benefit from the largest shares of foundation grant dollars. In 2013, foundation giving is expected to remain consistent, posting only modest growth. While many foundations will likely be able to keep their giving steady over the next year, some are expected to have to make further cuts in order to preserve profit margins. However, as businesses return to profitability and individuals’ wealth improves, they are likely to raise their charitable giving, thus boosting industry revenue. Furthermore, corporations and other for-profit groups will continue to open trusts and foundations as a way to promote a positive image of their organizations. For more information, visit IBISWorlds Donations, Grants & Endowment in the US industry report page.
Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189
IBISWorld industry Report Key Topics
This industry comprises organizations known as grantmaking foundations or charitable trusts. Establishments award grants from trust funds based on a competitive selection process or by the preferences of the foundation managers and grantors. Industry operators may also fund a single entity, such as a museum or university. Due to the unique structure of this industry, revenue is calculated by adding contributions, grants, investment income and realized gains.
Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios
About IBISWorld Inc.
Recognized as the nations most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.
Related Posts:
Los Angeles, CA (PRWEB) April 15, 2012
The Medical Device Manufacturing industry has enjoyed strong revenue growth recently and is forecast to continue expanding in the years ahead. Since 2007, revenue increased at an average annual rate of 12.8%, and sales are expected to grow 7.4% in 2012 alone, to $ 64.7 billion. The US economic downturn did little to deter hospitals and other customers from purchasing medical devices, according to IBISWorld industry analyst Nima Samadi. In fact, more industry companies gained sales in 2008 and 2009 than lost them. The aging US population is a major factor driving demand, as the occurrence of health issues that require medical devices is higher in the elderly population. This demographic is forecast to expand further as a percentage of the total population during the five years to 2017, which will help maintain industry growth.
But revenue in the Medical Device Manufacturing industry will not grow as quickly over the five years to 2017. The changing regulatory environment will be the main hindrance, Samadi said. For example, the Patient Protection and Affordable Care Act of 2010 will place an excise tax on medical devices, eating into revenue and reducing profit. Also, potential reform to the approval process for new devices will likely hamper innovation and encourage more companies to shift functions overseas.
Foreign outsourcing of manufacturing, research and development and other operations, combined with industry consolidation, is forecast to decrease the number of industry operators during the next five years. This industry has traditionally had a low level of industry concentration, with no one firm dominating. Small operators are common in this type of industry, and typically specialize in developing technology and products for a niche area. Larger players frequently seek to acquire these firms to expand their product range or gain access to a particular technology. But during the five years to 2012, consolidation has swept the industry, with the number of companies decreasing at an average annual rate of 5.5% to total 828. Meanwhile, emerging markets like China and Brazil will attract medical device manufacturers, as US customers face more stringent Medicare reimbursement requirements and other cost-cutting pressures. For more information, visit IBISWorlds Medical Device Manufacturing report in the US industry page.
Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189
IBISWorld industry Report Key Topics
This industry includes manufacturers of electromedical and electrotherapeutic apparatus, such as magnetic resonance imaging equipment, medical ultrasound equipment, pacemakers, hearing aids, electrocardiographs and electromedical endoscopic equipment. The industry also manufactures irradiation apparatus and tubes for applications such as medical diagnostic, medical therapeutic, industrial, research and scientific evaluation.
Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios
About IBISWorld Inc.
Recognized as the nations most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.
Incoming search terms:
- ee uu approved microchip 2013
- h r 4872 national medical device registry
- ee uu approves microchip implant for 2013
- what is obama health care hr 4872 medical microchip
- usa approve microchip for patient in 2013
- obama law H R 3950
- national medical registry in hr3590
- national medical device registry hr 3590 hr 4872
- microchip patients health reform law ee uu 2013
- implanting of microchip in 2013 facebook